The Europe Health Care ETF market experienced a solid performance on 27 March, with most funds within the sector reflecting this upward trend. Notable ETFs include the iShares MSCI Europe Health Care Sector UCITS ETF and SPDR MSCI Europe Health Care UCITS ETF, both achieving a 1.98% daily return. Additionally, the iShares STOXX Europe 600 Health Care UCITS ETF (DE) posted a similar daily return of 1.93%. Meanwhile, Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF stood out as it remained unaffected by yesterday's market action.
This growth was primarily driven by the significant performance of leading healthcare companies. AstraZeneca (NASDAQ:AZN) PLC and Sanofi (EPA:SASY) SA surged, up by 1.79% and 1.38% respectively, contributing to the overall increase in the market. Novartis AG also demonstrated its strength in the sector, recording a staggering 7.71% daily return. On the other hand, Roche Holding (SIX:ROG) bucked the general trend by exhibiting a marginal decline of 0.58% yesterday. Nonetheless, the collective performance of these companies signals a positive outlook for the European Health Care ETF market.